Menu

Infographic: Triggering Titin

This third filament involved in muscle function is often ignored in medical textbooks. Here's how it works.

Sep 1, 2018
Julio M. Fernández

MUSCULAR DOGMA

The standard textbook model of muscle contraction includes only two main players, the filaments actin and myosin, which slide past each other, causing the sarcomere—the basic unit of muscle tissue—to shorten. Driven by ATP-powered myosin motors, sarcomere contraction causes whole muscles to shorten. In the past 40 years, researchers have explored the role of another filament: titin. Its emerging role in muscle function, unwinding during muscle relaxation and folding during contraction, suggests that the ATP-driven motors also act as latches allowing titin to fold, providing a powerful boost to muscle contraction.

© IKUMI KAYAMA/STUDIO KAYAMA

Relaxed

When sarcomeres are relaxed titin, anchored to teh Z line and the ends of myosin filaments, unwinds.
© IKUMI KAYAMA/STUDIO KAYAMA

Contracted

When sarcomeres contract, titin folds again, adding force to the contraction.
© ikumi kayama/studio kayama


Read the full story.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!